Pepcid AC

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pepcid AC

Property Description
Active ingredient Famotidine
Form Oral tablet, chewable tablet, oral suspension
Pharmacological class Histamine H2-receptor antagonist (H2-blocker)
Common use Relief of acid indigestion and heartburn symptoms
Origin Synthetic compound

Pharmacological Identity and Composition

Pepcid AC is a widely recognized trade name for the active chemical substance, Famotidine, which is a synthetic compound classified as a Histamine H2-receptor antagonist (H2-blocker). This pharmacological designation is the key to understanding its function, as it belongs to a class of medicines designed for systemic absorption to provide relief from discomfort associated with excess gastric acid. The composition is based on a single active ingredient, Famotidine, combined with standard inert pharmaceutical excipients.

The medication is primarily administered via the oral route, where it is available in several dosage forms, including the common oral tablet, the chewable tablet, and the liquid oral suspension. These varied forms ensure therapeutic flexibility, allowing users and healthcare professionals to select the most suitable method for delivery into the body.


General Purpose and Verified Action

The general purpose of Famotidine is to control and lower overall gastric acidity, thereby providing relief from symptoms like heartburn and sour stomach caused by acid overproduction. This action is recognized to be highly effective at reducing the production of stomach acid.

Famotidine achieves this benefit by acting as a targeted, reversible blocker on the H2-receptors located on the parietal cells in the stomach lining. This core mechanism inhibits the signaling pathway that normally stimulates acid secretion, leading to a demonstrable reduction in the total volume and concentration of gastric acid released. This provides the drug's primary therapeutic benefit for individuals experiencing common acid indigestion.

Regulatory References

  1. Famotidine: MedlinePlus Drug Information

What side effects are possible with Pepcid AC?

Possible side effects and safety information

The safety profile for Famotidine (Pepcid AC) is defined by classifications and observations documented in regulatory sources such as the FDA and EMA. Adverse reactions are grouped by frequency and the body system affected, ensuring a neutral, standardized description of potential risks.


Frequency and System-Organ Classifications

Adverse reactions are officially categorized to indicate likelihood, ranging from common to very rare.

  • Common Reactions are primarily observed in the Nervous System (e.g., headache, dizziness) and the Gastrointestinal System (e.g., diarrhea, constipation).
  • Uncommon Reactions include occurrences such as dry mouth, flatulence, nausea, vomiting, fatigue, and various skin reactions like rash and pruritus.

Serious Adverse Reactions and Safety Considerations

The most clinically significant adverse reactions are classified as Very Rare in regulatory documents. These serious concerns include instances of anaphylaxis and angioedema, severe blood disorders such as agranulocytosis and thrombocytopenia, seizures, and certain cardiac effects like QT interval prolongation.

Safety notes explicitly address specific populations and conditions. Due to altered drug clearance, older adults and individuals with renal impairment are noted to have an increased risk for CNS adverse reactions (e.g., confusion or delirium). The official label also requires caution for use in patients with pre-existing risk factors for QT interval prolongation. Additionally, symptomatic improvement while taking Famotidine does not rule out the presence of gastric malignancy, a key safety limitation noted in regulatory texts.

The official safety information structures the understanding of risks by categorizing effects based on their measured frequency and system involvement, distinguishing common, less serious effects from rarely occurring but clinically important adverse reactions.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Overdose of Pepcid AC (famotidine) is defined by official regulatory documentation detailing specific neurological and systemic manifestations. Documented Central Nervous System (CNS) effects that may present include confusion, delirium, hallucinations, agitation, and lethargy. Other documented manifestations include headache, dizziness, diarrhea, and constipation.

Regulators note the potential for severe outcomes, including seizures and cardiac rhythm disturbances, such as QT prolongation. These severe risks are explicitly associated with elevated systemic drug exposure.


When to Seek Urgent Medical Help

Official regulatory guidance mandates that you seek immediate medical attention or contact a Poison Control Center right away in all cases of suspected overdose. Emergency services should be called immediately if the individual has collapsed, experienced a seizure, or has trouble breathing.


Population-Specific Considerations and Management

The official prescribing information highlights that elderly patients and individuals with moderate to severe renal impairment face a higher likelihood of CNS and cardiac adverse reactions due to reduced clearance and resulting high systemic exposure. Treatment management is documented as symptomatic and supportive, often involving procedures such as the administration of activated charcoal and continuous ECG monitoring of vital signs.

Therapeutic Uses of Pepcid AC

Pepcid AC (famotidine) is an over-the-counter and prescription medication used across therapeutic domains where additional symptomatic support is needed. Its main therapeutic action is applied in addressing conditions marked by excess stomach acid production. This action may assist with easing symptoms related to physical discomfort and managing symptoms that interfere with daily functioning.

The primary over-the-counter applications for famotidine may assist with easing symptoms associated with acute or episodic changes, such as heartburn and acid indigestion. Famotidine is commonly used across conditions presenting with acute episodes of acid reflux.

Prescription strengths are considered relevant in contexts marked by increased discomfort or tension, such as duodenal and gastric ulcers, gastroesophageal reflux disease (GERD), and hypersecretory conditions. The use of famotidine may assist with maintaining functional stability and contributes to easing the overall symptom load, providing supportive relief when symptoms interfere with routine activities.

“The medication may assist with managing symptoms that interfere with daily comfort.”

Quick Fact: Relief for symptoms related to inflammatory or irritative states.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Regulatory Eligibility: Who Can and Cannot Use Pepcid AC?

Eligibility for Pepcid AC (famotidine) is strictly defined by regulatory documents, focusing on patient age, medical history, and physiological state.

Contraindications (Do Not Use)

  • Individuals with a known history of hypersensitivity or allergic reactions (such as anaphylaxis) to famotidine or any other H2-receptor antagonist (acid reducer) must not use this medicine.

Eligibility by Age and Status

Category Regulatory Status
Age Approved for use in adults and children 12 years of age and older. Children under 12 require consultation with a doctor.
Renal Function Patients with moderate to severe kidney disease or renal impairment should consult a doctor before use, as dosage adjustment may be needed due to altered drug clearance.
Pregnancy/Lactation Pregnant or breast-feeding women should ask a health professional before use, as use is conditional upon the medical assessment of potential benefit versus risk.

These official rules establish the essential boundaries for self-administration, requiring medical guidance for specific populations to ensure safe use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Famotidine (Pepcid AC) has a documented interaction profile primarily focused on its effect on gastric pH and its elimination pathways, as described in official government labeling. The main concern is a pharmacokinetic interaction where the reduction of stomach acid leads to altered absorption of co-administered medicines.

Documented Pharmacokinetic Interactions

Interaction Type Interacting Agent Official Regulatory Statement
pH-Dependent Absorption Medicines requiring acidic pH (e.g., Ketoconazole, Atazanavir) Reduction in gastric acid may cause decreased plasma concentrations and potential loss of therapeutic effect for these agents.
Metabolic ( CYP1 A2 Inhibition) Tizanidine Co-administration may substantially increase Tizanidine blood levels, a constraint noted in official prescribing information.
Elimination Pathway Competition Probenecid Inhibits the renal tubular secretion of Famotidine, resulting in elevated Famotidine plasma concentrations.

Administration Timing Constraints

Certain combinations require specific timing separation to prevent interference with drug exposure. Antacids (aluminum/magnesium-containing) or Sucralfate may reduce the absorption of Famotidine itself and should be administered 1 to 2 hours apart. Additionally, some pH-sensitive medicines like Ketoconazole require administration two hours before Famotidine to preserve their absorption.

Mechanism of Action

Histamine H2 Receptor Antagonism

Famotidine, the active ingredient in Pepcid AC, functions as a highly specific competitive antagonist that directly targets the histamine H2 receptors found on the acid-producing parietal cells of the stomach lining. By occupying these receptors, the drug blocks histamine—a natural signaling molecule—from binding and initiating the cell's acid production process.


Interruption of the Cellular Acid Secretion Pathway

This molecular blockade immediately interrupts the H2 R-linked intracellular signal cascade within the cell. The resulting disruption prevents the internal machinery from activating and mobilizing the proton pump—the final enzyme complex that releases acid into the stomach. This focused action on the cell's signaling pathways contributes to a sustained reduction in both basal and stimulated acid output.


Physiologically Adjusting Gastric Acidity

The systemic consequence of receptor antagonism and pathway interruption is a measurable decrease in the volume and concentration of hydrochloric acid ( HCl) released into the stomach lumen. This mechanism leads to a reduction and prolonged lowering of the gastric acidity (raising the pH), resulting in a sustained adjustment of the gastric physiological environment.

Dosage and Administration Information

Official Administration Guidelines for Famotidine

Famotidine (the active ingredient in Pepcid AC) is administered primarily via the oral route as a tablet or liquid suspension. An intravenous (IV) route is officially reserved as a temporary alternative for patients hospitalized and unable to take oral medication.

Standard Dosing and Frequency

Oral dosing schedules are set based on the condition being addressed, typically involving fixed doses of 20 mg or 40 mg. The medicine is commonly taken once daily at bedtime or twice daily (in the morning and at bedtime). For certain severe conditions, the starting dose is 20 mg every six hours, with a maximum dose of 160 mg every six hours.

Indication Type Typical Adult Dosage Duration Pattern
Active Ulcer Treatment 40 mg once daily or 20 mg twice daily Up to 8 weeks
Erosive Esophagitis 20 mg or 40 mg twice daily Up to 12 weeks
Ulcer Recurrence Reduction 20 mg once daily Up to 1 year

Administration Instructions

The tablets may be taken with or without food. For the oral suspension, the liquid form must be shaken vigorously before each dose is measured and administered. For the IV route, administration must be performed as an injection over at least 2 minutes or as an infusion over 15 to 30 minutes.

Population-Specific Dosing Rules

Official instructions mandate a dose reduction or interval extension for adults with moderate to severe renal impairment (creatinine clearance less than 60 mL/min). In this population, the dose may be reduced to 50% of the standard recommended dose to prevent drug accumulation. Pediatric patients weighing less than 40 kg are managed with weight-based dosing, and specific tablet strengths may not be suitable.

Recent Clinical Evidence

Research evidence / Overview of studies for Pepcid AC

Evidence for Short-Term Relief of Heartburn and Acid Indigestion

Research has explored the role of Famotidine in addressing conditions characterized by fluctuating or episodic manifestations, such as occasional heartburn and acid indigestion. Studies focusing on acute symptoms often utilize randomized, double-blind, placebo-controlled trials (RCTs). These trials were relevant in trials assessing short-term or episodic symptom patterns, primarily involving adult and adolescent populations. The main outcomes related to physical discomfort that were measured included the time elapsed until participants reported a measurable change in their symptoms, the total duration of observed symptom patterns, and whether the medicine was studied for its role in relation to meal-induced symptoms.

In these acute research scenarios, studies reported measured changes related to the time course of symptoms in the observed populations. Research highlights changes measured during the study period for outcomes describing episodic or acute changes. Some findings describe patterns observed in the studies, including measured differences in the consumption of rescue antacids by participants. However, the evidence is limited regarding long-term outcomes, as follow-up durations were limited.

Research on Gastroesophageal Reflux Disease (GERD) and Esophageal Healing

The use of Famotidine was studied for conditions involving periods of heightened symptoms, such as Gastroesophageal Reflux Disease (GERD) and associated esophageal erosions. Studies explored outcomes linked to inflammatory or irritative states, including patient-reported outcomes describing perceived discomfort and endoscopic assessment of measured tissue recovery rates for the esophageal lining. Findings indicate patterns related to changes in symptom manifestation, and research describes how symptoms evolved in the observed adult and pediatric populations.

Evidence for this indication in certain age groups remains limited. For instance, research conducted in pediatric patients, particularly infants, may present smaller sample sizes, making subgroup findings uncertain. Comparative evidence is lacking in some areas, as some systematic reviews note that research involving direct comparison with newer high-intensity acid suppression therapies for long-term GERD maintenance is not fully established.

Key Studies & References

  1. Famotidine - StatPearls - NCBI Bookshelf (Authoritative Monograph on Indications, Efficacy, and Use)

Frequently Asked Questions (FAQ)

Common questions about Pepcid AC (FAQ)


Q: How quickly does Pepcid AC typically start to work for heartburn relief?

Official product information indicates that the drug’s ability to reduce stomach acid typically begins within one hour after an oral dose. The peak acid-reducing effect is typically measured within one to three hours.


Q: What is the expected duration of heartburn relief from one dose of Pepcid AC?

Studies referenced in regulatory documents report that the drug provides acid reduction lasting up to 10-12 hours in some contexts. The duration of the effect is dependent on the specific dosage taken.


Q: Are there any known issues with taking Pepcid AC long-term?

The continuous use of over-the-counter famotidine (Pepcid AC) is generally limited to 14 days. If symptoms persist after 14 days, the official guidance is to consult with a health professional. Longer periods of use are directed by a health professional for specific prescription conditions.


Q: Does Pepcid AC have an effect on kidney function?

Famotidine is primarily processed and eliminated from the body by the kidneys. For individuals with existing moderate to severe kidney impairment, regulatory information indicates that dosage adjustment (reduction) may be necessary to prevent accumulation.


Q: Is Pepcid AC safe for use in older adults (seniors)?

Regulatory documents note that older adults may experience a slower clearance of the drug from the body. Due to this potential, there is an increased risk for Central Nervous System (CNS) side effects, such as confusion or dizziness. Regulatory documents note that dose adjustment may be necessary for older individuals due to the increased risk of certain side effects.


Q: Can this medication cause drowsiness or affect my ability to drive?

Dizziness and somnolence (drowsiness) have been reported as side effects. Regulatory documents recommend caution regarding operating machinery or driving, as effects on alertness can vary among individuals.


Q: How is the mechanism of action of Pepcid AC different from Tums or Rolaids?

Pepcid AC is classified as an H2-blocker and works systemically by reducing the amount of acid the stomach is able to secrete. Antacids, such as Tums or Rolaids, contain calcium or magnesium salts that act locally in the stomach to neutralize acid that is already present.


Q: Is Pepcid AC gluten-free or suitable for people with Celiac disease?

While the active ingredient is synthetic, formulations may vary by manufacturer. Some products are explicitly labeled as gluten-free. Patients with Celiac disease or specific dietary needs are directed to check the full list of inactive ingredients on the product label.


Q: Are there special considerations for taking Pepcid AC if I have liver problems?

The official product labeling requires consultation with a health professional before use if a patient has liver disease. Elevated liver enzymes have been reported in post-market surveillance.


Q: Can Pepcid AC interact negatively with caffeine or alcohol?

There is no direct pharmacological interaction listed between famotidine and alcohol or caffeine. Regulatory guidance suggests avoiding common heartburn triggers such as alcohol and caffeinated beverages as part of a complete management plan.


Q: Is it normal to feel a change in appetite after starting Pepcid AC?

Loss of appetite (anorexia) has been reported as an adverse reaction in clinical trials and post-market use. This effect is noted in regulatory documents among the reported adverse reactions.


Q: Has Pepcid AC been studied for use during pregnancy or while breastfeeding?

Studies indicate that famotidine is transferred into breast milk. Limited data exist on the full impact during pregnancy and breastfeeding. The official guidance is that pregnant or breastfeeding individuals must consult a health professional before use.


Q: Are there any research studies looking at the effects of Pepcid AC on children?

The medicine is approved for use in children 12 years of age and older. Official guidance indicates that for children under 12, use must be supervised by a health professional due to the requirement for specific weight-based dosing and formulation selection.


Q: Is there a maximum number of days Pepcid AC is meant to be used continuously?

For self-treatment of occasional heartburn, the over-the-counter labeling limits continuous use to a maximum of 14 days. If symptoms persist or worsen after 14 days, official guidance is to consult a health professional.


Q: What foods or drinks should be avoided while using Pepcid AC?

Regulatory guidance includes advice on modifying diet to support heartburn relief. This typically means avoiding common heartburn triggers such as rich, spicy, fatty or fried foods, chocolate, caffeine, and alcohol.


Q: Is Pepcid AC recommended for occasional or chronic heartburn?

Over-the-counter Pepcid AC is approved for the relief and prevention of occasional heartburn. If symptoms are chronic or frequent, the label directs users to consult a health professional.


Q: What is the difference between prescription Pepcid and over-the-counter Pepcid AC?

Prescription famotidine is available in higher dosage strengths and is directed for the treatment of long-term conditions like ulcers or severe GERD. Over-the-counter Pepcid AC contains lower strengths intended for short-term, self-managed symptoms.


Q: Are there any religious or dietary restrictions related to the ingredients of Pepcid AC?

The active ingredient is synthetic. However, inactive ingredients are not always consistent and may include substances like lactose. Patients are directed to review the complete list of inactive ingredients on the product packaging for compliance with any specific dietary restrictions.


Q: Does Pepcid AC contain aluminum or magnesium like some antacids?

The standard formulation of Pepcid AC, containing only famotidine, does not contain aluminum or magnesium. Note that combination products (e.g., Pepcid Complete), which contain antacids, do include magnesium hydroxide and calcium carbonate.


Q: What should I do if I miss a dose of Pepcid AC?

Official patient instructions state that if a dose is missed, it should be taken as soon as possible. If it is nearly time for the next scheduled dose, the missed dose must be skipped, and the patient should return to the regular schedule. Taking two doses at once is not advised.


Q: Does Pepcid AC affect blood pressure?

Changes in blood pressure are not listed as a common or frequent side effect in the official product labeling. However, regulatory documents do acknowledge very rare reports of serious effects on the cardiovascular system.


Q: Is it true that Pepcid AC can interact with certain types of heart medications?

Famotidine can interact with certain medications by lowering stomach pH, which may reduce the absorption and effectiveness of some co-administered medicines. Regulatory documents caution that interactions can occur with pH-sensitive drugs. Consultation with a health professional regarding all concurrent medications is required.


Q: Does the time of day I take Pepcid AC matter for its effectiveness?

The timing can affect how the drug works for certain conditions. For instance, some uses include taking the drug at bedtime to suppress nocturnal acid secretion. For occasional heartburn, it can be taken preventatively 10 to 60 minutes before consuming food or drinks that might cause symptoms.


Q: Why do some people take Pepcid AC before eating a meal?

Official directions allow for the medicine to be taken 10 to 60 minutes before consuming meals or beverages that typically trigger heartburn. This pre-meal timing is described as a preventative measure to allow the acid-blocking action to begin working before symptoms start.


Q: Can Pepcid AC cause dry mouth or dry eyes?

Dry mouth is listed in official documentation as a reported gastrointestinal side effect. The side effect of dry skin is also listed, and red or irritated eyes have been noted in post-market surveillance.


Q: Is Pepcid AC safe to take with dietary supplements like fish oil or probiotics?

Famotidine’s main interaction pathway is through lowering stomach acid. Supplements that require an acidic stomach environment, such as some forms of iron, may have altered absorption. Regulatory guidance requires patients to inform their health professional of all concurrent supplements and vitamins, as pH-sensitive substances may have altered absorption.

How should Pepcid AC be stored and disposed of?

How to Store and Dispose of Pepcid AC?

The storage and disposal of Pepcid AC (famotidine) must follow official regulatory requirements to maintain product stability and ensure household safety.


Storage Conditions

Pepcid AC tablets must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The product must be protected from moisture and kept in its container, which should be kept tightly closed.

For the oral liquid suspension, the product must not be allowed to freeze, and any unused portion must be discarded after 30 days of opening or mixing.

All forms of the medication must be kept out of the sight and reach of children.


Disposal Requirements

Disposal of expired or unused Pepcid AC must be carried out in accordance with local regulations. If no local take-back program is available, the product may be mixed with an undesirable substance, sealed, and thrown into household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pepcid AC found in:

A-Z Index: